Neurocognitive Disorders

Hamilton Psychiatric Services in Hamilton, NJ offers comprehensive psychiatric evaluation and ongoing management for neurocognitive disorders, supporting patients and families across Mercer County through diagnosis, medication management, and coordinated care planning.

Neurocognitive disorders (NCDs) are a group of conditions defined by acquired decline in one or more cognitive domains — including memory, attention, language, executive function, and social cognition — from a previously higher level of performance. Unlike developmental conditions present from birth, neurocognitive disorders represent a deterioration from an established baseline and may be caused by a range of underlying neurological, vascular, metabolic, infectious, or psychiatric processes. Psychiatry plays a vital role in the management of neurocognitive disorders because behavioral and psychological symptoms — depression, anxiety, agitation, psychosis, sleep disturbance, and personality change — are among the most distressing and disruptive consequences of cognitive decline, for both the patient and their family.

Mild Neurocognitive Disorder (Mild Cognitive Impairment)

Mild neurocognitive disorder, commonly referred to as mild cognitive impairment (MCI), describes a level of cognitive decline that is greater than expected for the person's age and education but does not significantly interfere with independent daily functioning. Individuals with MCI can typically manage their own finances, medications, and household activities, though they may require more time, effort, or compensatory strategies to do so. Subjective complaints — forgetting names, losing track of conversations, misplacing objects more frequently than before — are often the first reported symptoms. A formal psychiatric or neuropsychological evaluation is important at this stage because MCI is not an inevitable consequence of aging: some individuals remain stable, some improve, and some progress to major neurocognitive disorder over time. Identifying treatable contributing factors — depression, medication side effects, thyroid dysfunction, vitamin deficiencies, sleep disorders — at the MCI stage offers the best opportunity for intervention.

Major Neurocognitive Disorder (Dementia)

Major neurocognitive disorder, the clinical term for dementia, involves cognitive decline significant enough to interfere with independence in everyday activities. The specific pattern of cognitive and behavioral symptoms depends substantially on the underlying cause. The most common etiologies include:

Alzheimer's Disease
Alzheimer's disease accounts for the majority of dementia diagnoses and is characterized by insidious onset and gradual progression. Early symptoms typically involve difficulty learning new information and recalling recent events, while remote memory and procedural skills are relatively preserved in early stages. As the disease advances, language impairment, visuospatial difficulties, disorientation to time and place, and significant changes in personality and behavior emerge. Neuropsychiatric symptoms such as depression, anxiety, apathy, agitation, and psychotic features are extremely common across all stages of Alzheimer's disease.

Vascular Neurocognitive Disorder
Vascular dementia results from cerebrovascular disease — stroke, transient ischemic attacks, or chronic small vessel disease — that disrupts blood supply to brain tissue. Cognitive impairment may develop suddenly following a stroke or accumulate gradually through repeated small vessel events. Executive dysfunction, processing speed slowing, and mood changes (including post-stroke depression) are frequently prominent features. Psychiatric management of neuropsychiatric symptoms alongside vascular risk factor reduction is central to care.

Lewy Body Dementia
Dementia with Lewy bodies (DLB) is characterized by fluctuating cognition and attention, well-formed visual hallucinations, parkinsonian motor features, and REM sleep behavior disorder. Psychiatric management of DLB requires specialized knowledge because many commonly used medications — including certain antipsychotics — can cause severe, potentially life-threatening adverse reactions in this population. Accurate diagnosis is therefore essential before initiating any pharmacological treatment.

Frontotemporal Neurocognitive Disorder
Frontotemporal dementia (FTD) primarily affects the frontal and temporal lobes and typically presents with prominent behavioral and personality changes — disinhibition, apathy, loss of empathy, compulsive behaviors, and socially inappropriate conduct — often before significant memory impairment develops. The behavioral variant of FTD can be mistakenly attributed to a psychiatric disorder, particularly late-onset depression or personality disorder, making longitudinal psychiatric evaluation and familiarity with the FTD spectrum critical to accurate diagnosis.

Behavioral and Psychological Symptoms of Dementia

Behavioral and psychological symptoms of dementia (BPSD) — including depression, anxiety, agitation, aggression, psychosis (hallucinations and delusions), sleep-wake cycle disruption, wandering, and sexual disinhibition — affect the majority of individuals with dementia at some point in their illness. These symptoms are frequently the primary driver of caregiver burden, premature institutionalization, and reduced quality of life for both patients and families. Psychiatric evaluation is essential to distinguish BPSD from acute medical illness (delirium), medication toxicity, pain, or primary psychiatric disorders — each of which requires a different management approach. Evidence-based non-pharmacological strategies are always the first line of intervention for BPSD, with pharmacotherapy reserved for symptoms causing significant distress or risk of harm when non-pharmacological approaches have been insufficient.

The Psychiatric Role in Neurocognitive Disorder Management

The psychiatrist's role in neurocognitive disorder care extends well beyond medication prescribing. At Hamilton Psychiatric Services, Dr. Mirza provides:

• Comprehensive psychiatric evaluation to characterize cognitive and neuropsychiatric symptoms, establish functional baseline, and contribute to differential diagnosis
• Identification and management of co-occurring psychiatric conditions — particularly depression and anxiety, which are highly prevalent in patients with cognitive impairment and can themselves exacerbate cognitive symptoms
• Assessment and management of delirium, which is a medical emergency requiring urgent evaluation and carries serious consequences if untreated
• Capacity assessments to help families and healthcare providers understand the patient's ability to make informed decisions about medical care and personal affairs
• Coordination with neurologists, primary care physicians, social workers, and other specialists to ensure cohesive, well-communicated care
• Ongoing monitoring of disease progression and treatment response, with timely adjustments to the care plan

Medication Management for Neurocognitive Disorders

Pharmacological treatment of neurocognitive disorders involves two distinct goals: slowing cognitive decline and managing neuropsychiatric symptoms. FDA-approved cognitive-enhancing medications — acetylcholinesterase inhibitors such as donepezil, rivastigmine, and galantamine, and the NMDA receptor antagonist memantine — can modestly slow cognitive decline and may improve function in Alzheimer's disease and certain other dementias. These medications do not cure or reverse the underlying disease process but can meaningfully extend the period of independent functioning for some patients.

For behavioral and psychological symptoms, medication management is guided by careful symptom characterization, the dementia subtype, the patient's overall medical status, and the risk-benefit profile of each agent. Antidepressants, anxiolytics, low-dose atypical antipsychotics (used with caution and only when clinically warranted), and sleep-targeted agents may each play a role depending on the predominant symptom burden. Dr. Mirza reviews all medications — including those prescribed by other providers — for potential interactions, cognitive side effects, and unnecessary polypharmacy, which is a modifiable risk factor for cognitive worsening in older adults.

Supporting Caregivers

Family members and informal caregivers of individuals with neurocognitive disorders carry an enormous physical, emotional, and financial burden. Caregiver stress, burnout, and depression are well-documented and serious health consequences. Hamilton Psychiatric Services recognizes that effective care for the patient necessarily involves supporting the people who care for them. Dr. Mirza takes time to explain the diagnosis, its expected trajectory, and practical management strategies in plain language. Guidance on safety planning — driving, financial decision-making, fall prevention, wandering risks — is provided in a way that respects both the patient's dignity and the family's need for realistic guidance. Referral to community resources, support groups, and social services is facilitated as needed.

When to Seek a Psychiatric Evaluation

A psychiatric evaluation is appropriate when a person or their family member notices concerning changes in memory, thinking, behavior, or personality — particularly when those changes are new, progressive, or interfering with daily life. Early evaluation is valuable because it allows treatable conditions to be identified, provides a cognitive baseline for future comparison, and gives families the information and support they need to plan ahead. You do not need to wait until symptoms are severe to seek help. Common reasons to schedule an evaluation include:

• Increasing forgetfulness that goes beyond typical age-related changes
• Difficulty managing finances, medications, or household responsibilities that were previously routine
• Personality or behavioral changes — increased irritability, apathy, suspiciousness, or social withdrawal
• Hallucinations, paranoid thinking, or other perceptual disturbances in an older adult
• Depression or anxiety accompanying cognitive concerns
• A family member with a known dementia diagnosis who is experiencing new or worsening behavioral symptoms

To schedule a psychiatric evaluation with Dr. Mirza at Hamilton Psychiatric Services, call 609-631-7770 or submit an appointment request online. We provide compassionate, expert care for patients and families navigating neurocognitive disorders throughout Hamilton, Trenton, and Mercer County, NJ.

Schedule a consultation — 609-631-7770  |  Request an Appointment Online